Clinical trial
Safety and Tolerability of SPD485 in Children Aged 6-12 Diagnosed With ADHD and…
NCT00151957 · Noven Therapeutics, Industry · Completed
Key facts
| NCT number | NCT00151957 |
|---|---|
| Title | Safety and Tolerability of SPD485 in Children Aged 6-12 Diagnosed With ADHD and Previously Participated in MTS Trials |
| Official title | A Phase III, Multi-center, Open-label Study of Methylphenidate Transdermal System (MTS) in Pediatric Patients Aged 6-12 With Attention-Deficit/Hyperactivity Disorder (ADHD) |
| Lead sponsor | Noven Therapeutics, Industry |
| Collaborators | Noven Pharmaceuticals, Inc. Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Attention Deficit Disorder With Hyperactivity |
| Intervention type | Drug |
| Interventions | Methylphenidate Transdermal System |
| Enrollment | 450 |
| Start date | Oct 1, 2004 |
| Primary completion | Jun 1, 2007 |
| Completion | Jun 1, 2007 |
| First posted | Sep 9, 2005 |
| Last update posted | Mar 28, 2017 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: